Anthem Blue Cross Blue Shield of California policy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor Therapy is a public Anthem Blue Cross Blue Shield of California policy (policy LAB.00042). It lists 1 CPT or HCPCS code, 1 of them on the Anthem Blue Cross Blue Shield of California prior authorization list. Not a coverage decision; the payer's own document governs.
Check eligibility for free
No account required. Sign a BAA to see plan details, coordination of benefits and more
- Policy number
- LAB.00042
- Line of business
- Commercial
- Source
- www.anthem.com
Codes in this policy
The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of California prior authorization list.
| Code | Prior authorization | Description on the prior authorization list | Other Anthem Blue Cross Blue Shield of California policies |
|---|---|---|---|
| 81599 | On the list | Unlisted multianalyte assay with algorithmic analysis | Policies naming 81599 |
All Anthem Blue Cross Blue Shield of California policies · Anthem Blue Cross Blue Shield of California prior authorization CPT list